Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

Sponsor
Northwestern University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05950438
Collaborator
(none)
25
1
58.5
0.4

Study Details

Study Description

Brief Summary

The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. We want to identify patients who will have this procedure. We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Esophagectomy

Detailed Description

Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract. Different surgical approaches and techniques have been developed, including open (transthoracic or transhiatal), minimally invasive (video-assisted thoracoscopic surgery or robotic-assisted), and hybrid approaches. These techniques may yield different clinical outcomes, and there is still ongoing debate regarding the optimal approach. Nevertheless, minimally invasive approaches, including robotic esophagectomy, are generally preferred given the lower morbidity. This prospective clinical registry aims to investigate outcomes of elective robotic transhiatal esophagectomy, the preferred approach at Northwestern Memorial Hospital, for adult patients undergoing this procedure. By collecting clinical and demographic data prospectively, we hope to identify factors that contribute to improved outcomes and guide future surgical practice.

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Clinical Registry Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
Actual Study Start Date :
Jul 11, 2023
Anticipated Primary Completion Date :
May 25, 2028
Anticipated Study Completion Date :
May 25, 2028

Outcome Measures

Primary Outcome Measures

  1. Number of Participants with Anastomotic Leak [During first 3 months postop]

    Postoperative Complication

  2. Number of Participants with Esophageal Stricture [During first 3 months postop]

    Postoperative Complication

  3. Number of Participants with Pneumonia [During first 3 months postop]

    Postoperative Complication

  4. Number of Participants Requiring Ventilation >48 Hours [During first 3 months postop]

    Postoperative Complication

  5. Number of Participants with Empyema [During first 3 months postop]

    Postoperative Complication

  6. Number of Participants with Pulmonary Embolism [During first 3 months postop]

    Postoperative Complication

  7. Number of Participants with Deep Venous Thrombosis [During first 3 months postop]

    Postoperative Complication

  8. Number of Participants with Gastric Outlet Obstruction [During first 3 months postop]

    Postoperative Complication

  9. Number of Participants with Stroke [During first 3 months postop]

    Postoperative Complication

  10. Number of Participants with Atrial Fibrillation [During first 3 months postop]

    Postoperative Complication

  11. Number of Participants with Vocal Cord Paralysis [During first 3 months postop]

    Postoperative Complication

  12. Number of Participants with Myocardial Infarction [During first 3 months postop]

    Postoperative Complication

  13. Number of Participants with Chylothorax [During first 3 months postop]

    Postoperative Complication

  14. Number of Participants with Acute Renal Injury [During first 3 months postop]

    Postoperative Complication

  15. Number of Participants with Wound Infections [During first 3 months postop]

    Postoperative Complication

  16. Rates of Re-operation [During first 3 months postop]

    Postoperative Complication

  17. Rates of Re-Admission [During first 3 months postop]

    Postoperative Complication

  18. Number of Participants with Intensive Care Unit (ICU) Stay [During first 3 months postop]

    Postoperative Complication

  19. Rates of Length of Hospital Stay [Postoperative]

    Postoperative Complication

  20. Rates of 30-day Survival [Postoperative]

    Postoperative Complication

  21. Rates of 90-day Survival Rates [Postoperative]

    Postoperative Complication

Secondary Outcome Measures

  1. Operative Time of Surgery [Intraoperative]

    Length of Surgery

  2. Rates of Blood Loss [Intraoperative]

    Did the Participant Lose Any Blood During the Surgery

  3. Number of Participants with Conversion Rates to Open Esophagectomy [Intraoperative]

  4. Number of Participants with Lymph nodes in the Final Specimen [Intraoperative]

    Pathological Variables

  5. Number of Participants with Proximal and Distal Margins [Intraoperative]

    Pathological Variables

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients (18 years or older)

  • Patients undergoing elective esophagectomy for any indication

  • Patients who have already had an elective esophagectomy for any indication

  • Patients with consent providing capacity

Exclusion Criteria:
  • Patients undergoing emergent esophagectomy

  • Adults unable to consent

  • Individuals who are not yet adults (infants, children, teenagers)

  • Pregnant women

  • Prisoners

  • Vulnerable Populations

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwestern University Chicago Illinois United States 60611

Sponsors and Collaborators

  • Northwestern University

Investigators

  • Principal Investigator: Ankit Bharat, MD, Northwestern University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ankit Bharat, Chief of Thoracic Surgery, Northwestern University
ClinicalTrials.gov Identifier:
NCT05950438
Other Study ID Numbers:
  • STU00219267
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 24, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ankit Bharat, Chief of Thoracic Surgery, Northwestern University

Study Results

No Results Posted as of Jul 24, 2023